|
Reference
|
1
|
Barany, E., Lindberg, M., Loden, M. (2000) Unexpected skin barrier influence from nonionic emulsifiers. Int J Pharm, 195(1-2): 189-95, https://www.sciencedirect.com/science/article/pii/S0378517399003889?via%3Dihub
|
|
Bárány, E. (2000) Dry skin and moisturizers. Boca Raton: CRC Press LLC, 243-250, https://www.crcpress.com/Dry-Skin-and-Moisturizers-Chemistry-and-Function/LodenMaibach/p/book/9780849321344
|
|
Baselga, E., Roe, E., Coulie, J., Muñoz, F.Z., Boon, L.M., Mccuaig, C., Hernandez-Martín, A., Gich, I., Puig, L. (2016) Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy. JAMA Dermatology, 152(11): 1239-1243
|
|
Bonifazi, E., Milano, A., Colonna, V. (2013) Evaluation of safety and efficacy of a galenic preparation of 1% propranolol in 89 cases of cutaneous infantile hemangioma. Eur J Pediat Dermatol, 23: 93-104, https://www.ejpd.com/journal/index.php/EJPD/article/view/922
|
|
Callender, V., Alexis, A., Stein, G.L., et al. (2018) Long-term topical oxymetazoline hydrochloride 1.0% demonstrates sustained and increasing effect in persistent facial erythema of rosacea. Journal of the American Academy of Dermatology, 79 (3), Supplement 1: AB182, https://www.jaad.org/issue/S0190-9622(18)X0002-4
|
1
|
Chiu, H., Tsai, T. (2011) Topical use of systemic drugs in dermatology: A comprehensive review. Journal of the American Academy of Dermatology, 65(5): 1048.e1-1048.e22, https://www.jaad.org/article/S0190-9622(10)01052-2/abstract
|
|
Corazza, M., Strumia, R., Lombardi, A.R., Virgili, A. (1996) Allergic contact dermatitis from spironolactone. Contact Dermatitis, 35(6): 365-366, https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-0536.1996.tb02421.x
|
|
Draelos, Z.D., Gold, M.H., Weiss, R.A., Baumann, L., Grekin, S.K., Robinson, D.M., Kempers, S.E., Alvandi, N., Weng, E., Berk, D.R., Ahluwalia, G. (2018) Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial. Journal of the American Academy of Dermatology, 78(6): 1156-1163, https://www.sciencedirect.com/science/article/pii/S0190962218301464
|
|
França, K., Litewka, S. (2019) Controversies in off-label prescriptions in dermatology: The perspective of the patient, the physician, and the pharmaceutical companies. International Journal of Dermatology, 58(7): 788-794, https://onlinelibrary.wiley.com/doi/10.1111/ijd.14222
|
|
Hoeger, P.H., Harper, J.I., Baselga, E., Bonnet, D., Boon, L.M., Degli, A.M.C., El, H.M., Oranje, A.P., Rubin, A.T., Weibel, L., Léauté-Labrèze, C. (2015) Treatment of infantile haemangiomas: Recommendations of a European expert group. European Journal of Pediatrics, 174(7): 855-865, https://link.springer.com/article/10.1007%2Fs00431-015-2570-0
|
|
Ilić, D., Cvetković, M., Blažević-Kamenov, N., Tasić-Kostov, M. (2019) Topical spironolactone in a natural non-ionic emulsifier based vehicle: A safety assessment. u: Skin and Formulation: 5th Symposium & 17th Skin Forum, Book of abstracts, pp. 57
|
|
Jakšić, I., Lukić, M., Malenović, A., Reichl, S., Hoffmann, C., Müller-Goymann, C., Daniels, R., Savić, S. (2012) Compounding of a topical drug with prospective natural surfactant-stabilized pharmaceutical bases: Physicochemical and in vitro/in vivo characterization: A ketoprofen case study. European Journal of Pharmaceutics and Biopharmaceutics, 80(1): 164-175, https://www.sciencedirect.com/science/article/pii/S0939641111002463?via%3Dihub
|
|
Ji, Y., Chen, S., Xu, C., Li, L., Xiang, B. (2015) The use of propranolol in the treatment of infantile haemangiomas: An update on potential mechanisms of action. British Journal of Dermatology, 172(1): 24-32, https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.13388
|
|
Kapoor, R., Phiske, M.M., Jerajani, H.R. (2009) Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo. British Journal of Dermatology, 160(4): 861-863, https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2133.2008.08923.x
|
|
Kelidari, H.R., Saeedi, M., Akbari, J., Morteza-Semnani, K., Gill, P., Valizadeh, H., Nokhodchi, A. (2015) Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids and Surfaces B: Biointerfaces, 128: 473-479, https://www.ncbi.nlm.nih.gov/pubmed/25797482
|
|
Kohler, C., Tschumi, K., Bodmer, C., et al. (2007) Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone. Gynecol Endocrinol, 23: 142-45, https://www.tandfonline.com/doi/abs/10.1080/09513590701214463?journalCode=igye20
|
|
Kunzi-Rapp, K. (2012) Topical propranolol therapy for infantile hemangiomas. Pediatric Dermatology, 29(2): 154-159, Epub ahead of print, https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1525-1470.2011.01615.x
|
|
Marqueling, A.L., Oza, V., Frieden, I.J., Puttgen, K.B. (2013) Propranolol and infantile hemangiomas four years later: A systematic review. Pediatric Dermatology, 30(2): 182-191, https://onlinelibrary.wiley.com/doi/abs/10.1111/pde.12089
|
|
Mashiah, J., Kutz, A., Rabia, S.H., Ilan, E.B., Goldberg, I., Sprecher, E., Harel, A. (2017) Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas. International Journal of Dermatology, 56(2): 148-153, https://onlinelibrary.wiley.com/doi/abs/10.1111/ijd.13517
|
|
Piana, M., Silva, M.A., Trevisan, G., de Brum, T.F., Silva, C.R., Boligon, A.A., Oliveira, S.M., Zadra, M., Hoffmeister, C., Rossato, M.F., Tonello, R., Laporta, L.V. (2013) Antiinflammatory effects of Viola tricolor gel in a model of sunburn in rats and the gel stability study. Journal of Ethnopharmacology, 150(2): 458-465, https://www.sciencedirect.com/science/article/pii/S0378874113005941?via%3Dihub
|
|
Price, A., Rai, S., Mcleod, R.W.J., Birchall, J.C., Elhassan, H.A. (2018) Topical propranolol for infantile haemangiomas: A systematic review. Journal of the European Academy of Dermatology and Venereology, 32(12): 2083-2089, https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.14963
|
|
Sato, K., Matsumoto, D., Iizuka, F., Aiba-Kojima, E., Watanabe-Ono, A., Suga, H., Inoue, K., Gonda, K., Yoshimura, K. (2006) Anti-androgenic therapy using oral spironolactone for Acne vulgaris in Asians. Aesthetic Plastic Surgery, 30(6): 689-694, https://link.springer.com/article/10.1007%2Fs00266-006-0081-0
|
|
Savić, M.M. (2013) Lekovi za dermatološku primenu - klasifikacija i mehanizmi dejstva. Arhiv za farmaciju, vol. 63, br. 2, str. 116-128
|
|
Stein-Gold, L., Kircik, L.H., Draelos, Z.D., Werschler, P., Dubois, J., Lain, E., Baumann, L., Goldberg, D.J., Kaufman, J., Tanghetti, E.A., Alvandi, N., Weng, E., Berk, D.R., Ahluwalia, G. (In press) Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials. Journal of the American Academy of Dermatology
|
|
Sugarman, J.H., Fleischer, A.B., Feldman, S.R. (2002) Off-label prescribing in the treatment of dermatologic disease. Journal of the American Academy of Dermatology, 47(2): 217-223, https://www.sciencedirect.com/science/article/pii/S0190962202000506?via%3Dihub
|
|
Tan, C.E.S., Itinteang, T., Leadbitter, P., Marsh, R., Tan, S.T. (2014) Low-dose propranolol regimen for infantile haemangioma. Journal of Paediatrics and Child Health, 51: 419-24, https://onlinelibrary.wiley.com/doi/abs/10.1111/jpc.12720
|
|
Tanghetti, E., Dover, J., Goldberg, D.J., et al. (2018) Topical oxymetazoline hydrochloride 1.0% effectively reduces persistent facial erythema of rosacea on day 1. Journal of the American Academy of Dermatology, 79 (3), Supplement 1: AB299, https://www.jaad.org/issue/S0190-9622(18)X0002-4
|
|
The Congress of the United States, Congressional Budget Office (2006) Research and development in the pharmaceutical industry. October, https://www.cbo.gov/sites/default/files/109thcongress-2005-2006/reports/10-02-drugr-d.pdf
|
|
Wang, Y., Zhang, X., Yang, Y., Zhang, J., Yang, Y., Lu, Y. (2017) Efficacy and safety of 2% topical propranolol cream for the treatment of proliferating infantile strawberry hemangiomas. Indian Journal of Pediatrics, 84(6): 425-429, https://link.springer.com/article/10.1007/s12098-017-2303-7
|
|
Xu, G., Lv, R., Zhao, Z., Huo, R. (2012) Topical propranolol for treatment of superficial infantile hemangiomas. Journal of the American Academy of Dermatology, 67(6): 1210-1213, https://www.sciencedirect.com/science/article/pii/S0190962212003507?via%3Dihub
|
|
Yamamoto, A., Ito, M. (1996) Topical spironolactone reduces sebum secretion rates in young adults. Journal of Dermatology, 23(4): 243-246, https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1346-8138.1996.tb04006.x
|
|
|
|